Jul 2026
The association of MASLD, lipoprotein(a) and long-term outcomes: Results from the multi-ethnic study of atherosclerosis.
BACKGROUND AND AIMS Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of cardiovascular events and frequently coexists with other atherosclerosis risk factors, including obesity, metabolic syndrome, sleep apnea, and insulin resistance. Lipoprotein(a) [Lp(a)] is a low-...
G. Nageswaran, V. Chidambaram, Amudha Kumar et al.
· Metabolism: Clinical and Exp... · 2 citations